Beraprost-314d Added-on to Tyvaso® (BEAT)

NCT01908699 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Beraprost Sodium 314d Modified Release Tablets
DRUG: Placebo

Sponsor

Lung Biotechnology PBC